Free Obama: The Moonshot, “Architecture and a Framework” for Cancer Research October 21, 2016Vol.42 No.39
Free Biden Delivers Task Force Report—Five Moonshot Goals in Cancer October 21, 2016Vol.42 No.39By Matthew Bin Han Ong
Drugs & Targets Genentech receives second Breakthrough Therapy Designation from FDA for Alecensa October 20, 2016Vol.39 No.09
Kyprolis Study in Newly Diagnosed Disease Doesn’t Meet Primary Endpoint—PFS October 20, 2016Vol.39 No.09
Novartis’s LEE011 + Letrozole Shows Superior PFS as First-Line Treatment for HR+/HER2- Advanced Breast Cancer October 20, 2016Vol.39 No.09